- Research article
- Open Access
Proteins other than the locus of enterocyte effacement-encoded proteins contribute to Escherichia coli O157:H7 adherence to bovine rectoanal junction stratified squamous epithelial cells
https://doi.org/10.1186/1471-2180-12-103
© Kudva et al.; licensee BioMed Central Ltd. 2012
Received: 9 February 2012
Accepted: 12 June 2012
Published: 12 June 2012
Abstract
Background
In this study, we present evidence that proteins encoded by the Locus of Enterocyte Effacement (LEE), considered critical for Escherichia coli O157 (O157) adherence to follicle-associated epithelial (FAE) cells at the bovine recto-anal junction (RAJ), do not appear to contribute to O157 adherence to squamous epithelial (RSE) cells also constituting this primary site of O157 colonization in cattle.
Results
Antisera targeting intimin-γ, the primary O157 adhesin, and other essential LEE proteins failed to block O157 adherence to RSE cells, when this pathogen was grown in DMEM, a culture medium that enhances expression of LEE proteins. In addition, RSE adherence of a DMEM-grown-O157 mutant lacking the intimin protein was comparable to that seen with its wild-type parent O157 strain grown in the same media. These adherence patterns were in complete contrast to that observed with HEp-2 cells (the adherence to which is mediated by intimin-γ), assayed under same conditions. This suggested that proteins other than intimin-γ that contribute to adherence to RSE cells are expressed by this pathogen during growth in DMEM. To identify such proteins, we defined the proteome of DMEM-grown-O157 (DMEM-proteome). GeLC-MS/MS revealed that the O157 DMEM-proteome comprised 684 proteins including several components of the cattle and human O157 immunome, orthologs of adhesins, hypothetical secreted and outer membrane proteins, in addition to the known virulence and LEE proteins. Bioinformatics-based analysis of the components of the O157 DMEM proteome revealed several new O157-specific proteins with adhesin potential.
Conclusion
Proteins other than LEE and intimin-γ proteins are involved in O157 adherence to RSE cells at the bovine RAJ. Such proteins, with adhesin potential, are expressed by this human pathogen during growth in DMEM. Ongoing experiments to evaluate their role in RSE adherence should provide both valuable insights into the O157-RSE interactions and new targets for more efficacious anti-adhesion O157 vaccines.
Keywords
Background
Escherichia coli (E. coli) O157 (O157) was first identified as a human enteric pathogen in 1982 and has since been implicated in several outbreaks and sporadic infections [1, 2]. Currently, this human pathogen ranks fourth after Campylobacter, Salmonella, and Shigella among the etiologic agents causing diarrhea in North America [3, 4]. Cattle are the primary reservoirs for O157, with the bovine recto-anal junction (RAJ) serving as the primary colonization site for O157. Humans acquire infection by consumption of undercooked beef products such as ground meat or foods contaminated with manure [1, 2].
The bovine RAJ comprises of two cell types, the follicle associated epithelium (FAE) towards the distal colon and the stratified squamous epithelium (RSE) closer to the anal canal [5]. Thus far, studies analyzing O157 persistence at the RAJ have focused primarily on its interactions with the FAE cells [6, 7]. Proteins encoded on the O157 pathogenicity island, Locus of Enterocyte Effacement (LEE), have been shown to play a critical role in O157 adherence to FAE cells. These include the E. coli secreted proteins EspA and EspB, the adhesin Intimin, and the translocated receptor for Intimin, Tir which is secreted via the LEE-encoded type III secretion system (TTSS) [6–8]. Hence, several pre-harvest control measures being evaluated in cattle to control or eliminate O157 from entering the food chain [9–14], include vaccines targeting these LEE-encoded proteins. For instance, Potter et al. developed a vaccine comprising wild-type O157 culture supernatants that contain the TTSS proteins, Tir and Esps [15]; however, similar protection was noted in animals inoculated with the culture supernatant from a mutant strain of O157 lacking the tir gene. In addition, the immune response of the vaccinated animals was not merely to the TTSS proteins but also against a number of other proteins that were present in the supernatant. Interestingly, although the vaccine decreased both the number of E. coli O157 shed in the feces of vaccinated animals, and those colonizing the terminal rectum, it did not reduce the duration of shedding despite the subcutaneous administration of three doses of the vaccine [15, 16]; http://www.bioniche.com. Similar results were also observed with another vaccine that targets the O157 siderophore receptor and porin (SRP) proteins [17, 18]; https://animalhealth.pfizer.com. This clearly suggests that unidentified proteins other than those constituting the TTSS or SRP may play a crucial role in bovine colonization, and that the identification and inclusion of such proteins is likely to increase the efficacy of vaccines for elimination of O157 from the gastrointestinal tracts of cattle. Further supporting this inference are reported observations that the TTSS proteins do not significantly contribute to the persistence of O157 in feedlot cattle [19], or to O157 invasion of crypt cells at the RAJ [20].
In a previous study, O157 was observed to adhere to RSE cells in vivo and in vitro, besides the FAE cells [5] and this observation was used to develop a unique in vitro adherence assay for O157 with RSE cells [5]. In this study, we decided to (i) evaluate if the LEE-encoded proteins would also be critical for O157 adherence to RSE cells, as for FAE cells, and (ii) in the event that these proteins would not play a significant role in RSE cell adherence, define the proteome of O157 as expressed when grown in the adherence assay media, DMEM, to assemble targets for future evaluation in RSE adherence. Experimental and bioinformatic evaluation of such targets could in fact help identify a subset of novel adhesins that may have excellent potential to increase the efficacy of the anti-adhesion, cattle O157 vaccines, by eliminating O157 from both FAE and RSE cells at the RAJ.
Methods
Bacterial strains and culture conditions
The wild-type O157 strain EDL933 (O157), a sequenced isolate implicated in human disease [21], was used in this study. We cultured O157 in Dulbecco Modified Eagle Medium-Low Glucose (DMEM; Gibco/lnvitrogen Corporation, Grand Island, NY), for the cell adherence assays described below. The rationale for the use of this culture medium was (i) to reflect the growth conditions used in the eukaryotic cell adherence assays; and (ii) to closely parallel the in vivo nutrient-limiting conditions, and conditions used to prepare the cattle-use approved, LEE protein based, anti-adhesion O157 vaccine. In addition, another wild-type O157 strain 86–24 (86–24), its isogenic mutant (86-24eae Δ10) negative for Intimin, and this mutant complemented with the plasmid pEB310 (86-24eae Δ10(pEB310)) expressing Intimin, were also tested in the adherence assay [22]. The 86–24 strain and its derivatives were obtained from Dr. A. D. O’Brien, Uniformed Services University of the Health Sciences, Bethesda, MD.
We also cultured O157 in DMEM for proteomic analysis. Specifically, an overnight culture of the wild-type O157 strain in Luria-Bertani (LB) broth was pelleted and washed with sterile phosphate buffered saline (PBS; pH 7.4), and subcultured to an initial OD600 of 0.05 in fresh DMEM. After incubation at 37 °C with shaking at 250 rpm to an OD600 of 0.8 to 1.0, cells were harvested by centrifugation at 7,000 rpm, 15 min at 4 °C. Cells were washed three times with an equal volume of sterile PBS (pH 7.4), and processed to obtain cell lysate and pellet fractions for proteomic analysis as previously described [23].
O157-RSE cell adherence inhibition assay: (i) in the presence of pooled anti-LEE proteins, anti-intimin and anti-H7 antisera
Adherence of O157 to the RSE cells was previously demonstrated and developed into an adherence assay in our laboratory [5]. In this study, the ability of pooled, rabbit polyclonal antisera to interfere with and inhibit O157 adherence to RSE cells was evaluated. Specifically, antisera generated against the recombinant LEE-encoded proteins, Tir, EspA and EspB, and Intimin, in rabbits (National Animal Disease Center Stocks), was pooled. Rabbit antisera targeting the O157 flagellar antigen H7 (Difco Laboratories, Inc., Detroit, MI) was also mixed into the pooled antisera, which was then tested at 1:5 and 1:10 dilutions. Specificity was confirmed by reacting each antiserum against both O157 cell lysates and the cognate protein in western blotting experiments (data not shown). Rabbit sera (Sigma-Aldrich, St. Louis, MO) from healthy animals (normal rabbit sera), at a 1:5 dilution, was used as a control.
(ii) In the presence of anti-Intimin antisera alone
To specifically evaluate the role of intimin, the rabbit anti-Intimin antisera was evaluated separately for its ability to prevent O157 adherence to RSE cells at 1:5 and 1:10 dilutions.
Each of the RSE adherence assays was conducted in 8 technical and 2 biological replicates as described previously [5], with minor modifications, as follows. RSE cells were washed and resuspended in 1 ml Dulbecco Modified Eagle Medium – No Glucose (DMEM-NG) ± 2.5% D + Mannose, in 16 x 100 mm glass tubes, to a final concentration of 105 cells/ml. Although Type 1 fimbriae are not expressed by O157, we included D + Mannose in parallel assays to cover any hitherto unknown transient expression especially in mutant strains. Bacterial pellets from overnight cultures in DMEM, incubated at 37°C without aeration, were resuspended in sterile saline with or without antisera (‘no sera’ control), and incubated at 37°C for 30 min. The bacteria-antibody mix was then added to the RSE cells suspension to final bacteria:cell ratio of 10:1, and the mixture incubated with aeration (37°C, 110 rpm, for 4 h). At the end of 4 h, the mixture was pelleted and washed thoroughly, once with 14 ml DMEM-NG, and twice with 14 mls of sterile, distilled water (dH2O) before reconstituting in 100 μl dH2O. Eight 2 μl drops of this suspension were placed on Polysine (Thermo Scientific Pierce) slides and dried overnight under direct light to quench non-specific fluorescence, before fixing in cold 95% ethanol for 10 min. The slides were then stained with 1% toluidine blue, or with fluorescence-tagged antibodies that specifically target O157 and the RSE cell cytokeratins as described previously [5]. Each experiment was then done in duplicate.
O157 adherence patterns on RSE cells were recorded as diffuse, or aggregative (clumps) for all positive interactions that involved direct association with the cells [5]. Scattered bacteria and bacterial micro-colonies not adhering to cell membranes were considered to be negative for adherence to the epithelial cells [5]. A total of 100–160 well dispersed RSE cells (10–20 cells per drop or chamber) were analyzed per slide as described previously [5]. The percent RSE cells with and without bacteria adhering to them were determined [5]. If more than 50% of RSE cells had >10 bacteria attached, the adherence was recorded as strongly positive. For >50% RSE cells with 1–10 adherent bacteria, the adherence was recorded as moderately positive. For less than 50% RSE cells with 1–5 adherent bacteria, the result was recorded as non-adherent.
O157-HEp-2 cell adherence inhibition assay
The role played by LEE-encoded proteins and Intimin in the adherence of O157 to HEp-2 cells, has already been defined previously [22] and hence, this assay was used for comparative reasons. The assay was conducted as described previously [5] except that, the washed bacterial pellets were incubated with or without antisera (‘no sera’ control), at 37°C for 30 min, prior to addition to the HEp-2 cells. Both the pooled antisera and anti-intimin antisera, as described above, were used at dilutions ranging from 1:5 to 1:100 in these assays. Each assay was conducted in duplicate, and in 3–6 chambers of the chamber slides per run. Slides were stained with 1% toluidine blue, or with fluorescence-tagged antibodies that specifically target O157 and the HEp-2 cell actin filaments as described previously [5] and adherence patterns recorded as for RSE cells (see above).
Adherence of 86–24, 86-24eae Δ10, and 86-24eae Δ10(pEB310), to RSE and HEp-2 cells
Wild-type 86–24 and its mutant derivatives were used to verify the role of Intimin directly and compare the results with that of the O157 adherence inhibition assays. This assay was conducted, recorded, as previously described and done in the absence of any antisera [5].
OneDimensional (1D) SDS-PAGE liquid chromatography tandem mass spectrometry (GeLC-MS/MS)
Top down proteomic analysis was done at the Harvard Partners Center for Genetics and Genomics, Cambridge, Massachusetts. O157 cell pellet and lysate fractions were concentrated using spin filters (MW cutoff 5000 Daltons; Vivascience Inc., Englewood, NY), fractionated on 1D SDS-PAGE, and digested in-gel with trypsin prior to tandem mass spectrometry (MS/MS) as described previously [23]. The rationale for incorporating a 1D SDS-PAGE fractionation step is that this modification reduces complexity of protein mixtures, permits a larger dynamic range of protein identification, and allows for significantly better reproducibility [24, 25].
For mass spectrometry (MS), samples were subjected to three different runs on an LCQ DECA XP plus Proteome X workstation (LCQ) from Thermo Finnigan as described earlier [23, 26]. For each run, 10 μL of each reconstituted sample was injected with a Famos Autosampler, and the separation was done on a 75 μm (inner diameter) x 20 cm column packed with C18 media running at a flow rate of 0.25 μl/min provided from a Surveyor MS pump with a flow splitter with a gradient of water, 0.1% formic acid and then 5% acetonitrile, 0.1% formic acid (5%-72%) over the course of 480 min (8.0 hour run). Between each set of samples, a standard of a 5 Angiotensin mix of peptides (Michrom BioResources) was run to ascertain column performance, and to observe any potential carryover that might have occurred. The LCQ was run in a top five configuration, with one MS scan and five MS/MS scans. Dynamic exclusion was set to 1 with a limit of 30 seconds.
Peptide identifications were made using SEQUEST (Thermo Finnigan) through the Bioworks Browser 3.2, as described previously [23]. Sequential database searches were performed using the O157 strains EDL933 and Sakai FASTA database from European Bioinformatics Institute http://www.ebi.ac.uk/newt/display using static carbamidomethyl-modified cysteines and differential oxidized methionines. These protein databases (Escherichia coli (strain Sakai/O157:H7/RIMD 0509952/EHEC) – Tax ID: 386585 and Escherichia coli (strain EDL933/ATCC 700927/O157:H7/EHEC) – Tax ID: 155864) have a total of 10,737entries. A reverse O157 strain EDL933 FASTA database was spiked in to provide noise and determine validity of the peptide hits, so that known and theoretical protein hits can be determined without compromising the statistical relevance of all the data [26]. The MS data was searched with a 2-Dalton window on the MS precursor with a 0.8 Dalton on the fragment ions. Peptide score cutoff values were chosen at cross-correlation values (Xcorr) of 1.8 for singly charged ions, 2.5 for doubly charged ions, and 3.0 for triply charged ions, along with delta rank scoring preliminary cutoff (deltaCN) values of 0.1, and cross-correlation normalized values (RSp) of 1. The cross-correlation values chosen for each peptide assured a high confidence match for the different charge states, while the deltaCN values ensured the uniqueness of the peptide hit. The RSp value of 1 ensured that the peptide matched the top hit in the preliminary scoring. At these peptide filter values, very few reverse database hits were observed, which permitted a higher confidence in the few single peptide protein identifications. Furthermore, single hit proteins were manually validated to ensure relevance.
Bioinformatics
Cellular location of proteins was determined using amino acid sequences of cognate proteins in the O157 sequence databases at http://www.ncbi.nlm.nih.gov/protein. In addition, extracytoplasmic proteins were verified for the presence of signal sequences using the program SignalP 3.0 at http://www.cbs.dtu.dk/services/SignalP, and subcellular localization of other proteins confirmed using the PSORT/PSORT-B program (http://psort.nibb.ac.jp/). Putative functions were determined by querying the Conserved Domain Database (CDD) at http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi Protein components of the O157 DMEM-proteome with adhesion potential were shortlisted using Vaxign, a reverse vaccinology based vaccine target prediction and analysis system at http://www.violinet.org that utilizes the SPAAN algorithm [27].
Results and discussion
Adherence patterns of O157 strain EDL 933 on RSE cells, in the presence of D + Mannose and +/− antisera. Panel A, in the presence of “pooled antisera” against LEE, Intimin and flagellar H7 proteins, and the anti-Intimin antisera alone, at 1:5 dilutions. Panel B, in the absence of any sera (No sera). The immunofluorescence (IF) stained slides are shown at 40x magnification. O157 have green fluorescence, cytokeratins’ of RSE cells have orange-red fluorescence, and their nuclei have blue fluorescence. The arrows in the adjacent toluidine blue (TB) stained slides, at 40x magnification, point to RSE-adherent O157.
Quantitative representation of the adherence patterns of O157 strains EDL 933, and 86–24 along with its mutant derivatives, on RSE and HEp-2 cells. Percent mean ± standard error of mean of cells with adherent bacteria or no bacteria, in the ranges shown in the legend, are depicted in each graph.
Adherence patterns of O157 strains on HEp-2 cells, in the presence of D + Mannose and +/− antisera. Panel A, O157 strain EDL933, in the presence of “pooled antisera” against LEE. Intimin and flagellar H7 proteins, and the anti-Intimin antisera alone, at 1:100 and 1:10 dilutions, respectively. Panel B, O157 strain EDL933, in the absence of any sera (No sera). Panel C, O157 strain 86–24 (Intimin-positive) and its mutant derivatives, 86-24eae Δ10 (Intimin-negative), and 86-24eae Δ10 (pEB310) (Initmin-positive) in the absence of any sera. The immunofluorescence (IF) stained slides are shown at 40x magnification. O157 have green fluorescence, actin filaments of HEp-2 cells have orange-red fluorescence, and their nuclei have blue fluorescence.
Adherence patterns of O157 strain 86–24 (Intimin-positive) and its mutant derivatives, 86-24 eae Δ10 (Intimin-negative) and 86-24 eae Δ10 (pEB310) (Initmin-positive), on RSE cells, in the presence of D + Mannose. The immunofluorescence (IF) stained slides are shown at 40x magnification. O157 have green fluorescence, cytokeratins’ of RSE cells have orange-red fluorescence, and their nuclei have blue fluorescence. The arrows in the adjacent toluidine blue (TB) stained slides, at 40x magnification, point to RSE-adherent O157.
In order to verify if proteins other than LEE proteins were being expressed by O157 upon growth in DMEM which could have a possible role in O157 adherence to RSE cells, we analyzed the O157 proteome as expressed in DMEM. While the proteome of O157 has been analyzed under various other growth conditions [30–33] we decided to evaluate the same following growth in DMEM for several reasons, such as (i) this was the media used to culture both bacteria and the RSE cells, separately, prior to the adherence assays, (ii) the media closely mimicked the nutrient-limiting conditions seen in vivo, and (iii) this media closely matched that used to develop a commercially available cattle, O157 vaccine [15, 16; http://www.bioniche.com. Our observations did not support a role for other host (RSE-cell)-derived factors in this adherence of O157 and hence, we did not evaluate RSE-cell adherence of O157 cultured in eukaryotic cell-conditioned media. This inference came from the fact that similar adherence results were obtained when DMEM was supplemented with norepinephrine (NE; DMEM-NE), a host neuroendocrine hormone that is encountered by O157 in vivo during the actual process of infection (data not shown). NE is reportedly a mimic of autoinduer 3 (AI-3), which regulates O157 virulence gene expression via quorum sensing [34]. Further, Intimin, its receptor, Tir, as well as EspB were expressed in equivalent amounts in both DMEM and DMEM-NE, as observed using western blotting by others [34], and by us, and also using top down proteomics by us (data not shown).
Bacterial cell localization of proteins comprising the O157 DMEM-proteome.
Bioinformatically determined putative adhesins in the O157 DMEM-Proteome
Protein Identity: Sequences not homologous [O-island] OR homologous [Backbone] toE. coliK12 MG1655 | Peptide Hits | Bacterial Cell Localization | Proteins identified by PELS1 | Proteins identified by IVIAT2 | Proteins associated with O157 viulence |
|---|---|---|---|---|---|
Tir: Translocated intimin receptor protein: O-island#148 | 3 | Extracellular | + | ||
Eae: Intimin: Adhesin; attaching and effacing protein: O-island #148 | 36 | Outer Membrane | + | ||
ChuA: Outer membrane heme/hemoglobin receptor; heme utilization/transport protein: O-island #140 | 13 | Outer Membrane | + | + | |
EspP: Serine protease; secreted autotransporter: pO157 | 6 | Outer Membrane | + | + | |
TerE: Putative tellurium resistance protein B (Putative phage inhibition, colicin resistance): O-island #43 | 35 | Cytoplasm | |||
Z2239: Putative outer membrane porin protein: O-island #62 | 2 | Outer Membrane | |||
FimG: Fimbrial Morphology: Backbone | 1 | Inner Membrane | |||
MsrA: Peptide methionine sulfoxide reductase : Backbone | 1 | Cytoplasm | |||
YjeI: Putative lipoprotein :Backbone | 2 | Non-cytoplasmic | |||
BtuB: Outer membrane receptor for transport of vitamin B12, E colicins, and bacteriophage: Backbone | 3 | Outer Membrane | |||
DsbA: Thiol:disulfide interchange protein precursor : Backbone | 8 | Periplasm | |||
PstS: High-affinity phosphate-specific transport system; periplasmic phosphate-binding protein: Backbone | 3 | Periplasm | |||
YiaF: Hypothetical protein: Backbone | 2 | Cytoplasm | |||
Slp: Outer membrane protein induced after carbon starvation: Backbone | 17 | Outer Membrane | |||
LivJ: Leu/Ile/Val-binding protein precursor; ABC transporter: Backbone | 2 | Periplasm | |||
PpiA: Peptidyl-prolyl cis-trans isomerase A precursor : Backbone | 4 | Cytoplasm | |||
YrbD: Hypothetical protein precursor; probable phospholipid ABC transporter-binding protein MlaD :Backbone | 1 | Periplasm | |||
YraP: Hypothetical protein; putative transport :Backbone | 2 | Periplasm | |||
TolC: Outer membrane channel; specific tolerance to colicin E1; segregation of daughter chromosome: Backbone | 3 | Outer Membrane | + | ||
Lpp: Murein-lipoprotein; major outer membrane lipoprotein precursor: Backbone | 31 | Outer Membrane | + | MepA, MltB, Slt | |
NlpB: Lipoprotein-34: Backbone | 3 | Outer Membrane | |||
Z3508: Hypothetical protein :Backbone | 1 | Non-cytoplasmic | |||
OmpC: Outer membrane protein 1b: hyperosmotic shock: Backbone | 123 | Outer Membrane | + | ||
YehZ: Putative transport system permease protein :Backbone | 1 | Cytoplasm | |||
CspC: Cold shock-like protein : Backbone | 25 | Cytoplasm | |||
CspD: Cold shock-like protein : Backbone | 1 | Cytoplasm | |||
CspE: Cold shock-like protein : Backbone | 9 | Cytoplasm | |||
YeaF: Hypothetical protein yeaF; putative scaffolding protein in the formation of a murein :Backbone | 4 | Outer Membrane | + | YeaA | |
OsmE: Osmotically inducible lipoprotein E precursor; activator of ntr-like gene : Backbone | 9 | Cytoplasm | |||
SlyB: Outer membrane lipoprotein slyB precursor : Backbone | 3 | Outer Membrane | |||
YciD: Putative outer membrane protein :Backbone | 1 | Outer Membrane | |||
YceI: Putative GTP binding :Backbone | 2 | Non-cytoplasmic | |||
ArtI: Arginine 3rd transport system periplasmic binding protein: Backbone | 1 | Periplasm | |||
YbiS: Putative transpeptidase :Backbone | 5 | Non-cytoplasmic | |||
OmpX: Outer membrane protein X precursor : Backbone | 22 | Outer Membrane | |||
FepA: Receptor for ferric enterobactin (Enterochelin) and colicins B and D: Backbone | 29 | Outer Membrane | + |
Conclusion
Proteins other than the LEE-encoded proteins are involved in O157 adherence to RSE cells at the bovine RAJ. Such proteins, with adhesin potential, are expressed by this human pathogen during growth in vitro, in DMEM. Three such putative adhesins, namely, ChuA, TerE, and a putative outermembrane porin protein on O-island #62, are currently under evaluation for their adherence potential. Such studies should provide both valuable insights into the O157-RSE interactions and new targets for more efficacious anti-adhesion O157 cattle vaccines.
Declarations
Acknowledgements
This work was supported by a US National Institutes of Health Grant R21 AI055963 to I.T.K. Intellectual property rights for the O157 proteome identified in this study are held by Massachusetts General Hospital, Boston, MA.
Excellent technical assistance provided by Bryan Wheeler at the National Animal Disease Center, Ames, IA, with the eukaryotic cell adherence/adherence-inhibition assays is acknowledged.
Disclaimer
Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer.
Authors’ Affiliations
References
- Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, Blake PA: Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med. 1998, 109: 705-712.View ArticleGoogle Scholar
- Kaper JB, O'Brien AD: Escherichia coli O157:H7 and other shiga toxin-producing E. coli strains. 1998, ASM Press, Washington, D.CGoogle Scholar
- Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M, Roy SL, Jones JL, Griffin PM: Foodborne illness acquired in the United States –Major pathogens. Emerg Infect Dis. 2011, 17: 7-15. 10.3201/eid1701.09-1101p1.PubMedPubMed CentralView ArticleGoogle Scholar
- Vital signs: Incidence and trends of infection with pathogens transmitted commonly through food-Foodborne diseases active surveillance network, 10 U.S. Sites, 1996--2010. MMWR. 2011, 60 (22): 749-755.Google Scholar
- Kudva IT, Dean-Nystrom E: Bovine recto-anal junction squamous epithelial (RSE) cell adhesion assay for studying Escherichia coli O157 adherence. J App Microbiol. 2011, 111: 1283-1294. 10.1111/j.1365-2672.2011.05139.x.View ArticleGoogle Scholar
- Li Y, Frey E, Mackenzie AMR, Finlay BB: Human response to Escherichia coli O157:H7 infection: Antibodies to secreted virulence factors. Infect Immun. 2000, 68: 5090-5095. 10.1128/IAI.68.9.5090-5095.2000.PubMedPubMed CentralView ArticleGoogle Scholar
- Naylor SW, Low JC, Besser TE, Mahajan A, Gunn GJ, Pearce MC, McKendrick IJ, Smith DG, Gally DL: Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemmorhagic Escherichia coli O157:H7 in the bovine host. Infect Immun. 2003, 71: 1505-1512. 10.1128/IAI.71.3.1505-1512.2003.PubMedPubMed CentralView ArticleGoogle Scholar
- Naylor SW, Roe AJ, Nart P, Spears K, Smith DGE, Low JC, Gally DL: Escherichia coli O157:H7 forms attaching and effacing lesions at the terminal rectum of cattle and colonization requires LEE4 operon. Microbiol. 2005, 151: 2773-2781. 10.1099/mic.0.28060-0.View ArticleGoogle Scholar
- Buchko SJ, Holley RA, Olson WO, Gannon VP, Veira DM: The effect of different grain diets on fecal shedding of Escherichia coli O157:H7 by steers. J Food Prot. 2000, 63: 1467-1474.PubMedGoogle Scholar
- Kudva IT, Hatfield PG, Hovde CJ: Effect of diet on the shedding of Escherichia coli O157:H7 in a sheep model. Appl Environ Microbiol. 1995, 61: 1363-1370.PubMedPubMed CentralGoogle Scholar
- Kudva IT, Jelacic S, Tarr PI, Youderian PA, Hovde CJ: Biocontrol of Escherichia coli O157 with O157-specific bacteriophages. Appl Environ Microbiol. 1999, 65: 3767-3773.PubMedPubMed CentralGoogle Scholar
- Murinda SE, Roberts RF, Wilson RA: Evaluation of colicins for inhibitory activity against diarrheagenic Escherichia coli strains, including serotype O157:H7. Appl Environ Microbiol. 1996, 62: 3196-3202.PubMedPubMed CentralGoogle Scholar
- Nurmi E, Nuotio L, Schneitz C: The competitive exclusion concept: development and future. Int J Food Microbiol. 1992, 15: 237-240. 10.1016/0168-1605(92)90054-7.PubMedView ArticleGoogle Scholar
- Zhao T, Doyle MP, Harmon BG, Brown CA, Mueller PO, Parks AH: Reduction of carriage of enterohemorrhagic Escherichia coli O157:H7 in cattle by inoculation with probiotic bacteria. J Clin Microbiol. 1998, 36: 641-647.PubMedPubMed CentralGoogle Scholar
- Potter AA, Klashinsky S, Li Y, Frey E, Townsend H, Rogan D, Erickson G, Hinkley S, Klopfenstein T, Moxley RA, Smith DR, Finlay BB: Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine. 2004, 22: 362-369. 10.1016/j.vaccine.2003.08.007.PubMedView ArticleGoogle Scholar
- Allen KJ, Rogan D, Finlay BB, Potter AA, Asper DJ: Vaccination with type III secreted proteins leads to decreased shedding in calves after experimental infection with Escherichia coli O157. Can J Vet Res. 2011, 75: 98-105.PubMedPubMed CentralGoogle Scholar
- Fox JT, Thomson DU, Drouillard JS, Thornton AB, Burkhardt DT, Emery DA, Nagaraja TG: Efficacy of Escherichia coli O157:H7 siderophore receptor/porin proteins–based vaccine in feedlot cattle naturally shedding E. coli O157. Foodborne Path Dis. 2009, 6: 893-899. 10.1089/fpd.2009.0336.PubMedView ArticleGoogle Scholar
- Thomson DU, Loneragan GH, Thornton AB, Lechtenberg KF, Emery DA, Burkhardt DT, Nagaraja TG: Use of a siderophore receptor and porin proteins-based vaccine to control the burden of Escherichia coli O157:H7 in feedlot cattle. Foodborne Path Dis. 2009, 6: 871-877. 10.1089/fpd.2009.0290.PubMedView ArticleGoogle Scholar
- Carlson BA, Nightingale KK, Mason GL, Ruby JR, Choat WT, Loneragan GH, Smith GC, Sofos JN, Belk KE: Escherichia coli O157:H7 strains that persist in feedlot cattle are genetically related and demonstrate an enhanced ability to adhere to intestinal epithelial cells. App Environ Microbiol. 2009, 75: 5927-5937. 10.1128/AEM.00972-09.View ArticleGoogle Scholar
- Sheng H, Wang J, Lim JY, Davitt C, Minnich SA, Hovde CJ: Internalization of Escherichia coli O157:H7 by bovine rectal epithelial cells. Front Microbiol. 2011, 2: 1-32.View ArticleGoogle Scholar
- Perna NT, Plunkett G, Burland V, Mau B, Glasner JD, Rose DJ, Mayhew GF, Evans PS, Gregor J, Kirkpatrick HA, Posfai G, Hackett J, Klink S, Boutin A, Shao Y, Miller L, Grotbeck EJ, Davis NW, Lim A, Dimalanta ET, Potamousis KD, Apodaca J, Anantharaman TS, Lin J, Yen G, Schwartz DC, Welch RA, Blattner FR: Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature. 2001, 409: 529-533. 10.1038/35054089.PubMedView ArticleGoogle Scholar
- McKee ML, O’Brien AD: Truncated enterohemmorhagic Escherichia coli (EHEC) O157:H7 intimin (EaeA) fusion proteins promote adherence of EHEC strains to HEp-2 cells. Infect Immun. 1996, 64: 2225-2233.PubMedPubMed CentralGoogle Scholar
- Kudva IT, Krastins B, Sheng H, Griffin RW, Sarracino DA, Tarr PI, Hovde CJ, Calderwood SB, John M: Proteomics-based expression library screening (PELS): a novel method for rapidly defining microbial immunoproteomes. Mol Cell Proteomics. 2006, 5: 514-519.View ArticleGoogle Scholar
- Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP: Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res. 2003, 2: 43-50. 10.1021/pr025556v.PubMedView ArticleGoogle Scholar
- Steen H, Mann M: The ABC's (and XYZ's) of peptide sequencing. Nat Rev Mol Cell Biol. 2004, 5: 699-711. 10.1038/nrm1468.PubMedView ArticleGoogle Scholar
- John M, Kudva IT, Griffin RW, Dodson AW, McManus B, Krastins B, Sarracino D, Progulske-Fox A, Hillman JD, Handfield M, Tarr PI, Calderwood SB: Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection. Infect Immun. 2005, 73: 2665-2679. 10.1128/IAI.73.5.2665-2679.2005.PubMedPubMed CentralView ArticleGoogle Scholar
- Sachdeva G, Kumar K, Jain P, Ramachandran S: SPAAN: a software program for prediction of adhesins and adhesin-like proteins using neural networks. Bioinformatics. 2005, 15: 483-491.View ArticleGoogle Scholar
- Mahajan A, Currie CG, Mackie S, Tree J, McAteer S, McKendrick I, McNeilly TN, Roe A, LaRagione RM, Woodward MJ, Glly DL, Smith DGE: An investigation of the expression and adhesin function of H7 flagella in the interaction of Escherichia coli O157:H7 with bovine intestinal epithelium. Cell Microbiol. 2009, 11: 121-137. 10.1111/j.1462-5822.2008.01244.x.PubMedView ArticleGoogle Scholar
- Xicohtencatl-Cortes J, Chacon ES, Saldana Z, Freer E, Giron JA: Interaction of Escherichia coli O157:H7 with leafy green produce. J Food Protect. 2009, 72: 1531-1537.Google Scholar
- Fagerquist CK, Garbus BR, Miller WG, Williams KE, Yee E, Bates AH, Boyle S, Harden LA, Cooley MB, Mandrell RE: Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight – time-of-flight mass spectrometry and top-down proteomics. Anal Chem. 2010, 82: 2717-2725. 10.1021/ac902455d.PubMedView ArticleGoogle Scholar
- Gunther NW, Pang H, Nunez A, Uhlich GA: Comparative proteomics of E. coli O157:H7: Two-dimensional gel electrophoresis vs. two-dimensional liquid chromatography separation. The Open Proteom J. 2010, 3: 26-34. 10.2174/1875039701003010026.View ArticleGoogle Scholar
- Tremoulet F, Duche O, Namane A, Martinie B, Labadie JA: Proteomic study of Escherichia coli O157:H7 NCTC 12900 cultivated in biofilm or in planktonic growth mode. FEMS Microbiol Lett. 2002, 215: 7-14.PubMedView ArticleGoogle Scholar
- Zheng S, Schneider KA, Barder TJ, Lubman DM: Two-dimensional liquid chromatography protein expression mapping for differential proteomic analysis of normal and O157:H7 Escherichia coli. Biotechniq. 2003, 35: 1202-1212.Google Scholar
- Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB: Bacteria-host communication: The language of hormones. PNAS. 2003, 100: 8951-8956. 10.1073/pnas.1537100100.PubMedPubMed CentralView ArticleGoogle Scholar
Copyright
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
